Inflammatory response of mast cells during influenza a virus infection is mediated by active infection and RIG-I signaling

Journal of Immunology

Volumn 190, Issue 9, 2013, Pages 4676-4684

  Graham, Amy C ^a   Hilmer, Kimberly M ^a   Zickovich, Julianne M ^a   Obar, Joshua J ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; HISTAMINE; LEUKOTRIENE; RETINOIC ACID INDUCIBLE PROTEIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HISTAMINE METABOLISM; HISTAMINE RELEASE; IMMUNE RESPONSE; IN VITRO STUDY; INFLUENZA A; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; MAST CELL; MAST CELL DEGRANULATION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS ISOLATION; VIRUS STRAIN;

ANIMALS; CHEMOKINES; DEAD-BOX RNA HELICASES; HISTAMINE; HUMANS; INFLAMMATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; LEUKOTRIENES; LUNG; MAST CELLS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; ORTHOMYXOVIRIDAE INFECTIONS; STAT6 TRANSCRIPTION FACTOR;

EID: 84876811222     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202096     Document Type: Article

References (69)

1. Taubenberger, J. K., and D. M. Morens. 2008. The pathology of influenza virus infections. Annu. Rev. Pathol. 3: 499-522. (Pubitemid 351488291)
2. Baskin, C. R., H. Bielefeldt-Ohmann, T. M. Tumpey, P. J. Sabourin, J. P. Long, A. García-Sastre, A. E. Tolnay, R. Albrecht, J. A. Pyles, P. H. Olson, et al. 2009. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl. Acad. Sci. USA 106: 3455-3460.
3. Perrone, L. A., J. K. Plowden, A. García-Sastre, J. M. Katz, and T. M. Tumpey. 2008. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 4: e1000115.
4. Kash, J. C., T. M. Tumpey, S. C. Proll, V. Carter, O. Perwitasari, M. J. Thomas, C. F. Basler, P. Palese, J. K. Taubenberger, A. García-Sastre, et al. 2006. Ge-nomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443: 578-581. (Pubitemid 44527293)
5. Baas, T., C. R. Baskin, D. L. Diamond, A. García-Sastre, H. Bielefeldt-Ohmann, T. M. Tumpey, M. J. Thomas, V. S. Carter, T. H. Teal, N. Van Hoeven, et al. 2006. Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics. J. Virol. 80: 10813-10828. (Pubitemid 44628927)
6. Teijaro, J. R., K. B. Walsh, S. Cahalan, D. M. Fremgen, E. Roberts, F. Scott, E. Martinborough, R. Peach, M. B. Oldstone, and H. Rosen. 2011. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146: 980-991.
7. Moiseeva, E. P., and P. Bradding. 2011. Mast cells in lung inflammation. Adv. Exp. Med. Biol. 716: 235-269.
8. Abraham, S. N., and A. L. St John. 2010. Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol. 10: 440-452.
9. Shelburne, C. P., and S. N. Abraham. 2011. The mast cell in innate and adaptive immunity. Adv. Exp. Med. Biol. 716: 162-185.
10. Klemm, S., J. Gutermuth, L. Hültner, T. Sparwasser, H. Behrendt, C. Peschel, T. W. Mak, T. Jakob, and J. Ruland. 2006. The Bcl10-Malt1 complex segregates Fc epsilon RI-mediated nuclear factor kappa B activation and cytokine production from mast cell degranulation. J. Exp. Med. 203: 337-347. (Pubitemid 43290843)
11. Supajatura, V., H. Ushio, A. Nakao, S. Akira, K. Okumura, C. Ra, and H. Ogawa. 2002. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest. 109: 1351-1359. (Pubitemid 34546900)
12. Marshall, J. S. 2004. Mast-cell responses to pathogens. Nat. Rev. Immunol. 4: 787-799. (Pubitemid 39336295)
13. Dietrich, N., M. Rohde, R. Geffers, A. Kröger, H. Hauser, S. Weiss, and N. O. Gekara. 2010. Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria. Proc. Natl. Acad. Sci. USA 107: 8748-8753.
14. Guhl, S., R. Franke, A. Schielke, R. Johne, D. H. Krüger, M. Babina, and A. Rang. 2010. Infection of in vivo differentiated human mast cells with han-taviruses. J. Gen. Virol. 91: 1256-1261.
15. King, C. A., R. Anderson, and J. S. Marshall. 2002. Dengue virus selectively induces human mast cell chemokine production. J. Virol. 76: 8408-8419. (Pubitemid 34809093)
16. Sugiyama, K. 1977. Histamine release from rat mast cells induced by Sendai virus. Nature 270: 614-615. (Pubitemid 8240777)
17. Burke, S. M., T. B. Issekutz, K. Mohan, P. W. Lee, M. Shmulevitz, and J. S. Marshall. 2008. Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood 111: 5467-5476.
18. Orinska, Z., E. Bulanova, V. Budagian, M. Metz, M. Maurer, and S. Bulfone-Paus. 2005. TLR3-induced activation of mast cells modulates CD8+ T-cell recruitment. Blood 106: 978-987. (Pubitemid 41076443)
19. St John, A. L., A. P. Rathore, H. Yap, M. L. Ng, D. D. Metcalfe, S. G. Vasudevan, and S. N. Abraham. 2011. Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc. Natl. Acad. Sci. USA 108: 9190-9195.
20. Brown, M. G., S. M. McAlpine, Y. Y. Huang, I. D. Haidl, A. Al-Afif, J. S. Marshall, and R. Anderson. 2012. RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection. PLoS ONE 7: e34055.
21. Furuta, T., L. A. Murao, N. T. Lan, N. T. Huy, V. T. Huong, T. T. Thuy, V. D. Tham, C. T. Nga, T. T. Ha, Y. Ohmoto, et al. 2012. Association of mast cell-derived VEGF and proteases in Dengue shock syndrome. PLoS Negl. Trop. Dis. 6: e1505.
22. Wang, Z., Y. Lai, J. J. Bernard, D. T. Macleod, A. L. Cogen, B. Moss, and A. Di Nardo. 2012. Skin mast cells protect mice against vaccinia virus by triggering mast cell receptor S1PR2 and releasing antimicrobial peptides. J. Immunol. 188: 345-357.
23. Clementsen, P., C. B. Jensen, C. Hannoun, M. Søborg, and S. Norn. 1988. Influenza A virus potentiates basophil histamine release caused by endotoxin-induced complement activation. Examination of normal individuals and patients with intrinsic asthma. Allergy 43: 93-99. (Pubitemid 18079862)
24. Grunewald, S. M., C. Hahn, G. Wohlleben, M. Teufel, T. Major, H. Moll, E. B. Bröcker, and K. J. Erb. 2002. Infection with influenza a virus leads to flu antigen-induced cutaneous anaphylaxis in mice. J. Invest. Dermatol. 118: 645-651. (Pubitemid 34309984)
25. de Vries, V. C., K. Pino-Lagos, E. C. Nowak, K. A. Bennett, C. Oliva, and R. J. Noelle. 2011. Mast cells condition dendritic cells to mediate allograft tolerance. Immunity 35: 550-561.
26. Grimbaldeston, M. A., C. C. Chen, A. M. Piliponsky, M. Tsai, S. Y. Tam, and S. J. Galli. 2005. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am. J. Pathol. 167: 835-848. (Pubitemid 41216366)
27. Nakano, T., T. Sonoda, C. Hayashi, A. Yamatodani, Y. Kanayama, T. Yamamura, H. Asai, T. Yonezawa, Y. Kitamura, and S. J. Galli. 1985. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J. Exp. Med. 162: 1025-1043. (Pubitemid 16248206)
28. Tsai, M., M. A. Grimbaldeston, M. Yu, S. Y. Tam, and S. J. Galli. 2005. Using mast cell knock-in mice to analyze the roles of mast cells in allergic responses in vivo. Chem. Immunol. Allergy 87: 179-197. (Pubitemid 43093188)
29. Rodriguez, A. R., J. J. Yu, A. K. Murthy, M. N. Guentzel, K. E. Klose, T. G. Forsthuber, J. P. Chambers, M. T. Berton, and B. P. Arulanandam. 2011. Mast cell/IL-4 control of Francisella tularensis replication and host cell death is associated with increased ATP production and phagosomal acidification. Mu-cosal Immunol. 4: 217-226.
30. Ketavarapu, J. M., A. R. Rodriguez, J. J. Yu, Y. Cong, A. K. Murthy, T. G. Forsthuber, M. N. Guentzel, K. E. Klose, M. T. Berton, and B. P. Arulanandam. 2008. Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4. Proc. Natl. Acad. Sci. USA 105: 9313-9318.
31. Xu, X., D. Zhang, N. Lyubynska, P. J. Wolters, N. P. Killeen, P. Baluk, D. M. McDonald, S. Hawgood, and G. H. Caughey. 2006. Mast cells protect mice from Mycoplasma pneumonia. Am. J. Respir. Crit. Care Med. 173: 219-225. (Pubitemid 43187895)
32. Josset, L., J. A. Belser, M. J. Pantin-Jackwood, J. H. Chang, S. T. Chang, S. E. Belisle, T. M. Tumpey, and M. G. Katze. 2012. Implication of inflammatory macrophages, nuclear receptors, and interferon regulatory factors in increased virulence of pandemic 2009 H1N1 influenza A virus after host adaptation. J. Virol. 86: 7192-7206.
33. Nigrovic, P. A., D. H. Gray, T. Jones, J. Hallgren, F. C. Kuo, B. Chaletzky, M. Gurish, D. Mathis, C. Benoist, and D. M. Lee. 2008. Genetic inversion in mast cell-deficient (Wsh) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. Am. J. Pathol. 173: 1693-1701.
34. Le Goffic, R., J. Pothlichet, D. Vitour, T. Fujita, E. Meurs, M. Chignard, and M. Si-Tahar. 2007. Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J. Immunol. 178: 3368-3372. (Pubitemid 46417600)
35. Lund, J. M., L. Alexopoulou, A. Sato, M. Karow, N. C. Adams, N. W. Gale, A. Iwasaki, and R. A. Flavell. 2004. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101: 5598-5603. (Pubitemid 38481202)
36. Diebold, S. S., T. Kaisho, H. Hemmi, S. Akira, and C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531. (Pubitemid 38314425)
37. Ichinohe, T., I. K. Pang, and A. Iwasaki. 2010. Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat. Immunol. 11: 404-410.
38. Thomas, P. G., P. Dash, J. R. Aldridge, Jr., A. H. Ellebedy, C. Reynolds, A. J. Funk, W. J. Martin, M. Lamkanfi, R. J. Webby, K. L. Boyd, et al. 2009. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 30: 566-575.
39. Allen, I. C., M. A. Scull, C. B. Moore, E. K. Holl, E. McElvania-TeKippe, D. J. Taxman, E. H. Guthrie, R. J. Pickles, and J. P. Ting. 2009. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 30: 556-565.
40. Ichinohe, T., H. K. Lee, Y. Ogura, R. Flavell, and A. Iwasaki. 2009. Inflam-masome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 206: 79-87.
41. Loo, Y. M., J. Fornek, N. Crochet, G. Bajwa, O. Perwitasari, L. Martinez-Sobrido, S. Akira, M. A. Gill, A. García-Sastre, M. G. Katze, and M. Gale, Jr. 2008. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82: 335-345. (Pubitemid 350309149)
42. Pichlmair, A., O. Schulz, C. P. Tan, T. I. Näslund, P. Liljeström, F. Weber, and C. Reis e Sousa. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 59-phosphates. Science 314: 997-1001. (Pubitemid 44749946)
43. Kato, H., O. Takeuchi, S. Sato, M. Yoneyama, M. Yamamoto, K. Matsui, S. Uematsu, A. Jung, T. Kawai, K. J. Ishii, et al. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441: 101-105.
44. Seth, R. B., L. Sun, C. K. Ea, and Z. J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682. (Pubitemid 41242633)
45. Kawai, T., K. Takahashi, S. Sato, C. Coban, H. Kumar, H. Kato, K. J. Ishii, O. Takeuchi, and S. Akira. 2005. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat. Immunol. 6: 981-988. (Pubitemid 41486182)
46. Xu, L. G., Y. Y. Wang, K. J. Han, L. Y. Li, Z. Zhai, and H. B. Shu. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19: 727-740. (Pubitemid 41316668)
47. Meylan, E., J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager, and J. Tschopp. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172. (Pubitemid 41509355)
48. Poeck, H., M. Bscheider, O. Gross, K. Finger, S. Roth, M. Rebsamen, N. Hannesschläger, M. Schlee, S. Rothenfusser, W. Barchet, et al. 2010. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflam-masome signaling for interleukin 1 beta production. Nat. Immunol. 11: 63-69.
49. Ishikawa, H., and G. N. Barber. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455: 674-678.
50. Chen, H., H. Sun, F. You, W. Sun, X. Zhou, L. Chen, J. Yang, Y. Wang, H. Tang, Y. Guan, et al. 2011. Activation of STAT6 by STING is critical for antiviral innate immunity. Cell 147: 436-446.
51. Rao, K. N., and M. A. Brown. 2008. Mast cells: multifaceted immune cells with diverse roles in health and disease. Ann. N. Y. Acad. Sci. 1143: 83-104.
52. Hu, Y., Y. Jin, D. Han, G. Zhang, S. Cao, J. Xie, J. Xue, Y. Li, D. Meng, X. Fan, et al. 2012. Mast cell-induced lung injury in mice infected with H5N1 influenza virus. J. Virol. 86: 3347-3356.
53. Grant, S. M., K. L. Goa, A. Fitton, and E. M. Sorkin. 1990. Ketotifen. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs 40: 412-448.
54. Hung, C. H., J. L. Suen, Y. M. Hua, W. Chiang, H. C. Chang, C. N. Chen, and Y. J. Jong. 2007. Suppressive effects of ketotifen on Th1-and Th2-related chemokines of monocytes. Pediatr. Allergy Immunol. 18: 378-384. (Pubitemid 47037909)
55. Hill, S. J., C. R. Ganellin, H. Timmerman, J. C. Schwartz, N. P. Shankley, J. M. Young, W. Schunack, R. Levi, and H. L. Haas. 1997. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol. Rev. 49: 253-278. (Pubitemid 27414915)
56. Galli, S. J., J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, C. M. Williams, and M. Tsai. 2005. Mast cells as "tunable" effector and im-munoregulatory cells: recent advances. Annu. Rev. Immunol. 23: 749-786. (Pubitemid 40563184)
57. Skoner, D. P., D. A. Gentile, P. Fireman, K. Cordoro, and W. J. Doyle. 2001. Urinary histamine metabolite elevations during experimental influenza infection. Ann. Allergy Asthma Immunol. 87: 303-306. (Pubitemid 32973299)
58. Brown, M. G., L. L. Hermann, A. C. Issekutz, J. S. Marshall, D. Rowter, A. Al-Afif, and R. Anderson. 2011. Dengue virus infection of mast cells triggers endothelial cell activation. J. Virol. 85: 1145-1150.
59. Marcet, C. W., C. D. St Laurent, T. C. Moon, N. Singh, and A. D. Befus. 2012. Limited replication of influenza A virus in human mast cells. Immunol. Res. DOI: 10.1007/s12026-012-8377-4.
60. Fukuda, M., H. Ushio, J. Kawasaki, F. Niyonsaba, M. Takeuchi, T. Baba, K. Hiramatsu, K. Okumura, and H. Ogawa. 2012. Expression and functional characterization of retinoic acid-inducible gene-I-like receptors of mast cells in response to viral infection. J. Innate Immun. DOI: 10.1159/000343895.
61. Dixit, E., S. Boulant, Y. Zhang, A. S. Lee, C. Odendall, B. Shum, N. Hacohen, Z. J. Chen, S. P. Whelan, M. Fransen, et al. 2010. Peroxisomes are signaling platforms for antiviral innate immunity. Cell 141: 668-681.
62. Horner, S. M., H. M. Liu, H. S. Park, J. Briley, and M. Gale, Jr. 2011. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc. Natl. Acad. Sci. USA 108: 14590-14595.
63. Nazmi, A., R. Mukhopadhyay, K. Dutta, and A. Basu. 2012. STING mediates neuronal innate immune response following Japanese encephalitis virus infection. Sci Rep 2: 347.
64. Varga, Z. T., I. Ramos, R. Hai, M. Schmolke, A. García-Sastre, A. Fernandez-Sesma, and P. Palese. 2011. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog. 7: e1002067.
65. Varga, Z. T., A. Grant, B. Manicassamy, and P. Palese. 2012. Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. J. Virol. 86: 8359-8366.
66. Dudek, S. E., L. Wixler, C. Nordhoff, A. Nordmann, D. Anhlan, V. Wixler, and S. Ludwig. 2011. The influenza virus PB1-F2 protein has interferon antagonistic activity. Biol. Chem. 392: 1135-1144.
67. Kulka, M., L. Alexopoulou, R. A. Flavell, and D. D. Metcalfe. 2004. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J. Allergy Clin. Immunol. 114: 174-182. (Pubitemid 39005135)
68. Holm, C. K., S. B. Jensen, M. R. Jakobsen, N. Cheshenko, K. A. Horan, H. B. Moeller, R. Gonzalez-Dosal, S. B. Rasmussen, M. H. Christensen, T. O. Yarovinsky, et al. 2012. Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING. Nat. Immunol. 13: 737-743.
69. Seo, Y. J., C. Blake, S. Alexander, and B. Hahm. 2010. Sphingosine 1-phosphate-metabolizing enzymes control influenza virus propagation and viral cytopathogenicity. J. Virol. 84: 8124-8131.